[HTML][HTML] NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson's disease
WM Curtis, WA Seeds, MP Mattson, PC Bradshaw - Cells, 2022 - mdpi.com
Dysfunctional mitochondrial quality control (MQC) is implicated in the pathogenesis of
Parkinson's disease (PD). The improper selection of mitochondria for mitophagy increases …
Parkinson's disease (PD). The improper selection of mitochondria for mitophagy increases …
[HTML][HTML] Neuroprotection and disease modification by astrocytes and microglia in Parkinson disease
S Takahashi, K Mashima - Antioxidants, 2022 - mdpi.com
Oxidative stress and neuroinflammation are common bases for disease onset and
progression in many neurodegenerative diseases. In Parkinson disease, which is …
progression in many neurodegenerative diseases. In Parkinson disease, which is …
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease
Q Shen, X Jv, X Ma, C Li, L Liu, W Jia, L Qu… - Acta Pharmacologica …, 2024 - nature.com
Cell senescence has been implicated in the pathology of Parkinson's disease (PD). Both
abnormal α-synuclein aggregation and iron deposition are suggested to be the triggers …
abnormal α-synuclein aggregation and iron deposition are suggested to be the triggers …
[HTML][HTML] Reactive and senescent astroglial phenotypes as hallmarks of brain pathologies
A Lazic, V Balint, D Stanisavljevic Ninkovic… - International Journal of …, 2022 - mdpi.com
Astrocytes, as the most abundant glial cells in the central nervous system, are tightly
integrated into neural networks and participate in numerous aspects of brain physiology and …
integrated into neural networks and participate in numerous aspects of brain physiology and …
[HTML][HTML] Extracellular alpha-synuclein: Sensors, receptors, and responses
R Domingues, R Sant'Anna, ACC da Fonseca… - Neurobiology of …, 2022 - Elsevier
Synucleinopathies are a group of progressive neurodegenerative diseases known for the
accumulation of insoluble aggregates containing the protein alpha-synuclein (aSyn) …
accumulation of insoluble aggregates containing the protein alpha-synuclein (aSyn) …
[HTML][HTML] Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications
L Soraci, ME Gambuzza, L Biscetti, P Laganà… - Journal of …, 2023 - Springer
Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder
characterized by motor and non-motor disturbances as a result of a complex and not fully …
characterized by motor and non-motor disturbances as a result of a complex and not fully …
Restoration of adult neurogenesis by intranasal administration of gangliosides GD3 and GM1 in the olfactory bulb of A53T alpha-synuclein-expressing Parkinson's …
Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting
the body and mind of millions of people in the world. As PD progresses, bradykinesia …
the body and mind of millions of people in the world. As PD progresses, bradykinesia …
Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
H Wu, J Wei, X Zhao, Y Liu, Z Chen… - Bioengineering & …, 2023 - Wiley Online Library
Considerable evidence suggests that insulin resistance is closely linked to Parkinson's
disease (PD), leading to agents aiming at treating diabetes can be regarded as new …
disease (PD), leading to agents aiming at treating diabetes can be regarded as new …
Molecular mechanisms of cellular senescence in neurodegenerative diseases
HJ Lee, YS Yoon, SJ Lee - Journal of molecular biology, 2023 - Elsevier
Neurodegenerative diseases, such as Alzheimer's and Parkinson's, are characterized by
several pathological features, including selective neuronal loss, aggregation of specific …
several pathological features, including selective neuronal loss, aggregation of specific …
[HTML][HTML] Neuroglial senescence, α-synucleinopathy, and the therapeutic potential of senolytics in Parkinson's disease
SJ Miller, CE Campbell, HA Jimenez-Corea… - Frontiers in …, 2022 - frontiersin.org
Parkinson's disease (PD) is the most common movement disorder and the second most
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …
prevalent neurodegenerative disease after Alzheimer's disease. Despite decades of …